A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis
Clinical trial NCT01052194 · COMPLETED
Trial details
- NCT number
- NCT01052194
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-07-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.